Creatine for the Brain: The Energy Buffer Behind a Clear Mind

Key Takeaways:

• Oral creatine reaches the brain: in a magnetic resonance spectroscopy study, four weeks of supplementation raised total brain creatine by an average of 8.7 percent, with wide person-to-person variation, and the change reversed after stopping.
• A systematic review of six randomized trials in 281 healthy people found that creatine may improve short-term memory and reasoning, that vegetarians responded better than meat-eaters on memory tasks, and that results in other cognitive domains were conflicting.
• In a randomized trial of 52 women with major depression, adding 5 grams of creatine a day to escitalopram produced greater improvement in depression scores than placebo as early as week two, an effect that held at week eight.

Creatine has a reputation as a gym supplement, but the brain runs on the same chemistry as a sprinting muscle, and that is why interest in creatine for the brain has grown. Every thought, memory, and signal depends on a steady supply of ATP, the cell’s energy currency, and neurons cannot afford for that supply to dip even for seconds. Creatine is the buffer that keeps it level. Inside the cell, the enzyme creatine kinase attaches a phosphate group to creatine to form phosphocreatine, a compact reservoir of high-energy phosphate. When demand spikes, the reaction runs in reverse and phosphocreatine hands its phosphate back to ADP, regenerating ATP almost instantly while the slower machinery of the mitochondria catches up. The body makes some creatine on its own from three amino acids, and the rest comes from meat and fish, which is why people who eat little or no animal food tend to run lower stores. The question was whether swallowing extra creatine actually changes anything above the neck, since the brain is protected by a selective barrier. Imaging answered it. Using proton magnetic resonance spectroscopy, researchers measured brain chemistry before and after four weeks of high-dose creatine and found total brain creatine rose by an average of 8.7 percent, most of all in the thalamus. The rise varied widely from person to person, from about 3.5 to 13.3 percent, and it faded once supplementation stopped.

A reserve matters most when the brain is under strain, and the clearest human signals come from exactly those conditions. Sleep deprivation is thought to deplete brain creatine, so one double-blind trial loaded volunteers with creatine or placebo for a week and then kept them awake for 24 hours with intermittent light exercise. By the end of the night, the creatine group had lost significantly less ground on choice reaction time, balance, a demanding random-movement task, and mood. In rested, healthy people the effects are more modest and less consistent. A systematic review of six randomized trials covering 281 participants concluded that creatine may improve short-term memory and intelligence or reasoning, while findings for attention, executive function, reaction time, and mental fatigue were conflicting, and performance in young adults generally did not change. Diet shaped the response: vegetarians responded better than meat-eaters on memory tasks, which fits the idea that a lower starting reserve leaves more room to fill. The most intriguing signal comes from depression, where altered brain energy metabolism has long been observed. In an eight-week randomized, double-blind trial, 52 women with major depressive disorder started escitalopram plus either 5 grams of creatine a day or placebo. The creatine group improved more on the Hamilton Depression Rating Scale as early as week two, and the advantage held at weeks four and eight, with no difference in overall side effects.

Is creatine for the brain worth considering?

For some people it is a reasonable, low-risk conversation, as long as the evidence is described at its true size. The cognitive trials are small, most lasted days to weeks, and the sleep-deprivation study used a short, high-dose loading phase rather than the modest daily amount most people take, so the results show a plausible effect rather than a proven everyday benefit. The depression trial enrolled only women, used creatine as an add-on to an antidepressant rather than a substitute, and needs replication in larger and more diverse groups; nobody should stop or delay prescribed treatment in favor of a supplement. The practical case is strongest for people with a low starting reserve, such as vegetarians and vegans, and for periods of heavy mental demand or short sleep. Safety is one of creatine’s strengths. Controlled clinical trials do not support the old worry that it damages healthy kidneys, but there is one lab quirk worth knowing: creatine converts spontaneously into creatinine, so supplementation can nudge serum creatinine upward without any loss of kidney function. Anyone taking creatine should mention it before blood work, so a slightly high creatinine is interpreted correctly (a cystatin C test, which creatine does not affect, can confirm kidney function if there is any doubt), and people with existing kidney disease should decide with their clinician, since that group has been studied far less. Plain creatine monohydrate, the form used in the research, is the sensible choice.

References:

1. Dechent, P., Pouwels, P. J., Wilken, B., Hanefeld, F., & Frahm, J. (1999). Increase of total creatine in human brain after oral supplementation of creatine-monohydrate. The American Journal of Physiology, 277(3), R698-R704.
2. McMorris, T., Harris, R. C., Swain, J., Corbett, J., Collard, K., Dyson, R. J., et al. (2006). Effect of creatine supplementation and sleep deprivation, with mild exercise, on cognitive and psychomotor performance, mood state, and plasma concentrations of catecholamines and cortisol. Psychopharmacology, 185(1), 93-103.
3. Avgerinos, K. I., Spyrou, N., Bougioukas, K. I., & Kapogiannis, D. (2018). Effects of creatine supplementation on cognitive function of healthy individuals: A systematic review of randomized controlled trials. Experimental Gerontology, 108, 166-173.
4. Lyoo, I. K., Yoon, S., Kim, T. S., Hwang, J., Kim, J. E., Won, W., et al. (2012). A randomized, double-blind placebo-controlled trial of oral creatine monohydrate augmentation for enhanced response to a selective serotonin reuptake inhibitor in women with major depressive disorder. The American Journal of Psychiatry, 169(9), 937-945.
5. Longobardi, I., Gualano, B., Seguro, A. C., & Roschel, H. (2023). Is it time for a requiem for creatine supplementation-induced kidney failure? A narrative review. Nutrients, 15(6), 1466.